Perrigo has received FDA approval to market Nasonex® 24Hr Allergy (mometasone furoate monohydrate) 50mcg nasal spray as an over the counter (OTC) drug. Previously, mometasone nasal spray required a prescription.

• Nasonex was formerly a brand name prescription drug made by Merck Pharmaceuticals. After Merck discontinued the product, mometasone nasal spray was only available from generic manufacturers. The prescription version of the drug is indicated to treat allergies and nasal
• Perrigo’s OTC product is indicated for the temporary relief of symptoms of hay fever or other upper respiratory allergies. The company plans to launch Nasonex 24Hr Allergy later this year.